169 related articles for article (PubMed ID: 36975535)
1. Development of Digital Droplet PCR Targeting the Influenza H3N2 Oseltamivir-Resistant E119V Mutation and Its Performance through the Use of Reverse Genetics Mutants.
Van Poelvoorde LAE; Dufrasne FE; Van Gucht S; Saelens X; Roosens NHC
Curr Issues Mol Biol; 2023 Mar; 45(3):2521-2532. PubMed ID: 36975535
[TBL] [Abstract][Full Text] [Related]
2. [Development of a real-time reverse transcriptase PCR assay for detection of E119V amino acid change in neuraminidase of influenza A (H3N2) using the TaqMan-MGB probe].
Zhao X; Huang WJ; Wei HJ; Wang Z; Li XY; Cheng YH; Tan MJ; Xiao N; Lan Y; Guo JF; Sui HT; Zhu WF; Du DD; Wang DY; Shu YL
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 May; 47(5):448-51. PubMed ID: 23958130
[TBL] [Abstract][Full Text] [Related]
3. Characterization of oseltamivir-resistant influenza virus populations in immunosuppressed patients using digital-droplet PCR: Comparison with qPCR and next generation sequencing analysis.
Pichon M; Gaymard A; Josset L; Valette M; Millat G; Lina B; Escuret V
Antiviral Res; 2017 Sep; 145():160-167. PubMed ID: 28780426
[TBL] [Abstract][Full Text] [Related]
4. Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9).
Gaymard A; Charles-Dufant A; Sabatier M; Cortay JC; Frobert E; Picard C; Casalegno JS; Rosa-Calatrava M; Ferraris O; Valette M; Ottmann M; Lina B; Escuret V
J Antimicrob Chemother; 2016 Nov; 71(11):3036-3045. PubMed ID: 27432605
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.
Richard M; Ferraris O; Erny A; Barthélémy M; Traversier A; Sabatier M; Hay A; Lin YP; Russell RJ; Lina B
Antimicrob Agents Chemother; 2011 Jun; 55(6):2942-52. PubMed ID: 21422222
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens.
Marjuki H; Mishin VP; Sleeman K; Okomo-Adhiambo M; Sheu TG; Guo L; Xu X; Gubareva LV
Antimicrob Agents Chemother; 2013 Nov; 57(11):5209-15. PubMed ID: 23917311
[TBL] [Abstract][Full Text] [Related]
7. Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice.
Tang J; Gao R; Liu L; Zhang S; Liu J; Li X; Fang Q; Feng Z; Xu C; Huang W; Wang D
Sci Rep; 2021 Aug; 11(1):16293. PubMed ID: 34381119
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient.
Pontoriero A; Avaro M; Benedetti E; Russo M; Czech A; Periolo N; Campos A; Zamora A; Baumeister E
Mem Inst Oswaldo Cruz; 2016 Dec; 111(12):745-749. PubMed ID: 27849220
[TBL] [Abstract][Full Text] [Related]
9. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
[TBL] [Abstract][Full Text] [Related]
11. Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) viruses.
Tamura D; Okomo-Adhiambo M; Mishin VP; Guo Z; Xu X; Villanueva J; Fry AM; Stevens J; Gubareva LV
Antimicrob Agents Chemother; 2015 Apr; 59(4):2374-9. PubMed ID: 25645846
[TBL] [Abstract][Full Text] [Related]
12. The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant.
Simon P; Holder BP; Bouhy X; Abed Y; Beauchemin CA; Boivin G
J Clin Microbiol; 2011 Feb; 49(2):715-7. PubMed ID: 21106781
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction.
Sato M; Honzumi K; Sato T; Hashimoto K; Watanabe M; Miyazaki K; Kawasaki Y; Hosoya M
J Clin Virol; 2015 Jul; 68():97-103. PubMed ID: 26071346
[TBL] [Abstract][Full Text] [Related]
14. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment.
Tamura D; Nguyen HT; Sleeman K; Levine M; Mishin VP; Yang H; Guo Z; Okomo-Adhiambo M; Xu X; Stevens J; Gubareva LV
Antimicrob Agents Chemother; 2013 Dec; 57(12):6141-6. PubMed ID: 24080660
[TBL] [Abstract][Full Text] [Related]
15. Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay.
Nakauchi M; Ujike M; Obuchi M; Takashita E; Takayama I; Ejima M; Oba K; Konomi N; Odagiri T; Tashiro M; Kageyama T;
J Med Virol; 2011 Jul; 83(7):1121-7. PubMed ID: 21567417
[TBL] [Abstract][Full Text] [Related]
16. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.
Baz M; Abed Y; McDonald J; Boivin G
Clin Infect Dis; 2006 Dec; 43(12):1555-61. PubMed ID: 17109288
[TBL] [Abstract][Full Text] [Related]
17. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS).
Whitley RJ; Boucher CA; Lina B; Nguyen-Van-Tam JS; Osterhaus A; Schutten M; Monto AS
Clin Infect Dis; 2013 May; 56(9):1197-205. PubMed ID: 23307766
[TBL] [Abstract][Full Text] [Related]
18. Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.
Okomo-Adhiambo M; Demmler-Harrison GJ; Deyde VM; Sheu TG; Xu X; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2010 May; 54(5):1834-41. PubMed ID: 20194700
[TBL] [Abstract][Full Text] [Related]
19. Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.
Duan S; Boltz DA; Li J; Oshansky CM; Marjuki H; Barman S; Webby RJ; Webster RG; Govorkova EA
Antimicrob Agents Chemother; 2011 Oct; 55(10):4718-27. PubMed ID: 21730113
[TBL] [Abstract][Full Text] [Related]
20. Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis.
Redlberger-Fritz M; Aberle SW; Strassl R; Popow-Kraupp T
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1593-601. PubMed ID: 22089329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
